Finance

Lists
DVAI34:BVMF
Davita Inc BDR
R$ 912.73
0.00%
(0.00) 1D
9-р сарын 30, 16:36:42 (GMT-3)  ·   BRL
All symbols
SymbolPriceChange% Change
Generating top insights for DVAI34...
Mkt. cap
11.25 тэрбум
Avg. vol.
7.00
Volume
0.00
52-wk high
R$ 1,253.26
52-wk low
R$ 546.63
Shares outstanding
63.80 сая
No. of employees
78 мян
Mkt. cap
11.25 тэрбум
Avg. vol.
7.00
Volume
0.00
52-wk high
R$ 1,253.26
52-wk low
R$ 546.63
Shares outstanding
63.80 сая
No. of employees
78 мян
News stories
From web sources and news partners
AD HOC NEWS
AD HOC NEWS
·
19 цагийн өмнө
Wall Street Zen downgrades DaVita stock to Hold
Stock Traders Daily
Stock Traders Daily
·
1 өдрийн өмнө
Understanding Momentum Shifts in (DVA)
Yahoo Finance
Yahoo Finance
·
1 өдрийн өмнө
DaVita Inc. (DVA) Stock Forecasts
Profile
DaVita Inc. is an American health care company, incorporated in Delaware and headquartered in Denver, that provides kidney dialysis services through a network of 2,657 outpatient centers in the United States. DaVita serves 200,500 patients, and has 585 outpatient centers in 14 other countries serving 94,500 patients. The company primarily treats end-stage renal disease, which requires patients to undergo kidney dialysis, often 3 times per week for the rest of their lives unless they receive a kidney transplant via organ donation. In 2025, 68% of the company's revenues came from Medicare and other government-based health insurance programs. In 2025, 89% of the company's patients were covered by government-based health insurance programs. Commercial payers, which accounted for 32% of revenues in 2025, generate nearly all of the company's profit as they reimburse at a much higher rate than government-based health insurance programs. The company is ranked 331st on the 2026 Fortune 500. Wikipedia
About Davita Inc BDR
CEOJavier J. Rodriguez
Employees78 мян
Founded1992
HeadquartersДенвер, Колорадо, Америкийн Нэгдсэн Улс
SectorHealth care provider
Websitedavita.com
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
2025 оны 9-р сар
2025 оны 12-р сар
2026 оны 3-р сар
2026 оны 6-р сар
Revenue
3.42 тэрбум
3.62 тэрбум
3.42 тэрбум
3.55 тэрбум
Cost of goods sold
2.33 тэрбум
2.41 тэрбум
2.34 тэрбум
2.39 тэрбум
Cost of revenue
2.33 тэрбум
2.41 тэрбум
2.34 тэрбум
2.39 тэрбум
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
402.67 сая
472.36 сая
421.91 сая
423.46 сая
Operating expense
580.16 сая
659.06 сая
599.74 сая
591.27 сая
Total operating expenses
2.91 тэрбум
3.07 тэрбум
2.94 тэрбум
2.98 тэрбум
Operating income
507.30 сая
551.20 сая
473.55 сая
570.82 сая
Other non operating income
-17.26 сая
-21.03 сая
639.00 мян
4.47 сая
EBT including unusual items
308.80 сая
382.76 сая
341.23 сая
435.01 сая
EBT excluding unusual items
351.55 сая
391.79 сая
341.23 сая
437.04 сая
Income tax expense
68.55 сая
76.73 сая
66.20 сая
91.79 сая
Effective tax rate
22.20%
20.05%
19.40%
21.10%
Other operating expenses
-
-
-
-
Net income
150.33 сая
234.22 сая
197.53 сая
265.40 сая
Net profit margin
4.40%
6.47%
5.78%
7.47%
Earnings per share
2.51
3.40
2.87
4.02
Interest and investment income
-
-
-
-
Interest expense
-148.66 сая
-148.25 сая
-141.30 сая
-146.42 сая
Net interest expenses
-148.66 сая
-148.25 сая
-141.30 сая
-146.42 сая
Depreciation and amortization charges
177.49 сая
186.70 сая
177.83 сая
167.81 сая
EBITDA
684.80 сая
737.91 сая
651.38 сая
738.62 сая
Gain or loss from assets sale
-
-17.55 сая
-
-
AI content may include mistakes. Learn more
Google аппс